资讯

Baby Aasmika with SMA Type 1 received Zolgensma, the world’s most expensive gene therapy, thanks to India's largest-ever ...
Substandard cancer medications threaten patient safety across sub-Saharan Africa due to poor regulation and oversight.
A new urine-based tumor DNA (utDNA) test shows promise in predicting treatment response and recurrence risk, helping ...
Challenging traditional weight-focused care, the limits of lifestyle interventions and urges for more inclusive, health-centred approach.
Amid a measles outbreak, 79% of Americans back school vaccine rules, stressing the need to build trust and combat hesitancy ...
FDA approves Gamifant® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation ...
Higher intake of Vitamin B is linked to a lower risk of constipation, highlighting the importance of nutrition for digestive ...
ProBio, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today announced the opening of its flagship Cell and Gene Therapy Center of ...
PR Newswire ATLANTA, June 27, 2025 ATLANTA, June 27, 2025 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that the Phase 3 study investigating the safety ...
Distinct patterns of brain inflammation identified through PET imaging may explain disease progression and severity in ...
South Korea–based biotech firm LUCA AICELL has developed LUCA V-Defense Nasal Spray, a drug-free nasal spray designed to form a protective barrier on the nasal lining—offering a modern solution in the ...
Severe postpartum bleeding raises long-term cardiovascular risks in women, with effects lasting up to 15 years.